ArticleClinical cancer research : an official journal of the American Association for Cancer Research2009

Zoledronic acid inhibits both the osteolytic and osteoblastic components of osteosarcoma lesions in a mouse model.

Agatha Labrinidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.